RCKTROCKET PHARMACEUTICALS, INC.
Pharmaceutical Preparations · $267M market cap · 202 employees
1.3×
More likely than average to be bought by an AI rollup
Top 12% of the Russell 3000. How it works
Deal filings
Key numbers
- Revenue
- $0
- Operating margin
- —
- EBITDA
- −$223M
- 16% YoY
- Net debt / EBITDA
- —
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | |
| Operating income | −$167M | −$224M | −$260M | −$273M | −$232M | 15% |
| Net income | −$169M | −$222M | −$246M | −$259M | −$223M | 14% |
| Operating cash flow | −$121M | −$178M | −$195M | −$210M | −$190M | 9.4% |
| Capex | $8M | $8M | $16M | $6M | $440K | 92% |
| Stock-based comp | $29M | $31M | $39M | $44M | $37M | 16% |
| Buybacks | $0 | — | — | — | — |